Ruth Clifford
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.
Journal: European journal of haematology
Published: June 30, 2026
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation.
Journal: HemaSphere
Published: February 06, 2026
Circulating Tumor DNA and Immune Response Markers for Improved Treatment Outcome Prediction in Diffuse Large B-Cell Lymphoma: A Scoping Review.
Journal: Hematological oncology
Published: January 06, 2026
Living with chronic lymphocytic leukaemia: A qualitative evidence synthesis of patient, caregiver and practitioner perspectives.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: January 05, 2026
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.
Journal: The New England journal of medicine
Published: December 08, 2025
Cancer clinical trial recruitment for patients from rural areas: a scoping review.
Journal: International journal for equity in health
Published: December 01, 2025
Closing the gap of older adult recruitment to cancer clinical trials: a scoping review.
Journal: BMC cancer
Published: November 07, 2025
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.
Journal: Leukemia
Published: October 13, 2025
Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia.
Journal: Scientific reports
Published: March 20, 2025
Lymphoma follow-up pathway: A 10-year study to guide practice.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: October 24, 2024
Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot.
Journal: Irish journal of medical science
Published: March 22, 2024
Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors.
Journal: Journal of cellular and molecular medicine
Published: April 07, 2022
Last Updated: 09/26/2026